StockWatch
·
Pharmaceuticals
Shareholding26 Aug 2026, 05:30 pm

Deutsche Bank Discloses Piramal Pharma Share Pledge Update

AI Summary

Deutsche Bank AG, Mumbai Branch, acting as the onshore security agent for CA Alchemy Investments, has filed a disclosure under SEBI's Takeover Regulations. This update concerns the re-creation of a pledge over 98,400,000 equity shares of Piramal Pharma Limited, representing 7.39% of the total issued and paid-up share capital. Following this re-creation, Deutsche Bank AG holds a total pledge over 238,663,700 equity shares, amounting to 17.93% of the company's issued and paid-up share capital. The bank clarifies it holds no beneficial interest in these shares, acting solely as a pledgee.

Key Highlights

  • Deutsche Bank discloses re-creation of pledge on Piramal Pharma shares.
  • 98.4 million shares, 7.39% of capital, are newly re-pledged.
  • Total pledged shares now stand at 238.66 million (17.93% of capital).
  • Deutsche Bank acts as pledgee, holding no beneficial interest.
  • Disclosure is under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.